Journal Article
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
A. Laupacis, D. Feeny, A. S. Detsky and P. X. Tugwell
CMAJ February 15, 1992 146 (4) 473-481;
A. Laupacis
D. Feeny
A. S. Detsky
![Loading Loading](https://www.cmaj.ca/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article Information
vol. 146 no. 4 473-481
PubMed
History
- Published online February 15, 1992.
Copyright & Usage
Copyright © 1992 by Canadian Medical Association
Author Information
Statistics from Altmetric.com
In this issue
Article tools
Respond to this article
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations
A. Laupacis, D. Feeny, A. S. Detsky, P. X. Tugwell
CMAJ Feb 1992, 146 (4) 473-481;
Related Articles
- No related articles found.
Cited By...
- Cost-Utility Analysis of PCSK9 Inhibitors and Quality of Life: A Two-Year Multicenter Non-Randomized Study
- Cost-effectiveness and willing-to-pay thresholds for vertebral augmentation of osteoporotic vertebral fractures, what are they based on: a systematic review
- Cost-Effectiveness of an Extended Home Visit Program for Oxygen-Dependent COPD Patients
- Cost-Effectiveness of a Diabetes Self-Management Education and Support Intervention Led by Community Health Workers and Peer Leaders: Projections From the Racial and Ethnic Approaches to Community Health Detroit Trial
- Health economic evaluation in ophthalmology
- Cost-effectiveness of Community-Based Depression Interventions for Rural and Urban Adults With Type 2 Diabetes: Projections From Program ACTIVE (Adults Coming Together to Increase Vital Exercise) II
- Cost-effectiveness of antithrombotic agents for atrial fibrillation in older adults at risk for falls: a mathematical modelling study
- The impact of urban speed reduction programmes on health system cost and utilities
- Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study
- Model-based projection of health and economic effects of screening for hepatitis C in Canada
- Drug therapies for chronic hepatitis C infection: a cost-effectiveness analysis
- Willingness to pay per quality-adjusted life year for life-saving treatments in Thailand
- Should Patients with Autosomal Dominant Polycystic Kidney Disease Be Screened for Cerebral Aneurysms?
- Cost-Effectiveness of Ventricular Assist Device Therapy as a Bridge to Transplantation Compared With Nonbridged Cardiac Recipients
- Approach to economic evaluation in primary care: Review of a useful tool for primary care reform
- Economics of hematopoietic cell transplantation
- The Cost-Effectiveness of Single-Row Compared with Double-Row Arthroscopic Rotator Cuff Repair
- In A Survey, Marked Inconsistency In How Oncologists Judged Value Of High-Cost Cancer Drugs In Relation To Gains In Survival
- Cost-Utility Analysis of Primary Prophylaxis Versus Secondary Prophylaxis With Granulocyte Colony-Stimulating Factor in Elderly Patients With Diffuse Aggressive Lymphoma Receiving Curative-Intent Chemotherapy
- Adding Specialized Clinics for Remote-Dwellers with Chronic Kidney Disease: A Cost-Utility Analysis
- A Cost-Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke
- The Cost-Effectiveness of C-Reactive Protein Testing and Rosuvastatin Treatment for Patients With Normal Cholesterol Levels
- Is Mechanical Clot Removal or Disruption a Cost-Effective Treatment for Acute Stroke?
- Clinical Practice Guidelines for the Treatment of Metastatic Renal Cell Carcinoma: Today and Tomorrow
- Digital Mammography Workflow
- Population based screening for chronic kidney disease: cost effectiveness study
- The cost-effectiveness of screening for colorectal cancer
- Differences Between Out-of-Hospital Cardiac Arrest in Residential and Public Locations and Implications for Public-Access Defibrillation
- Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review
- Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes
- Cost-effectiveness of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin
- Value and cost in less invasive spinal fusion surgery: lessons from a community hospital
- Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
- Modeling the Cost-Effectiveness of Colorectal Cancer Screening: Policy Guidance Based on Patient Preferences and Compliance
- Cost-effectiveness of insulin analogues for diabetes mellitus
- The cost-effectiveness of Vancouver's supervised injection facility
- Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastatic Renal Cell Carcinoma
- Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy
- Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates
- The Cost-Effectiveness of Computer-Assisted Navigation in Total Knee Arthroplasty
- Economic Analysis of NCIC CTG JBR.10: A Randomized Trial of Adjuvant Vinorelbine Plus Cisplatin Compared With Observation in Early Stage Non-Small-Cell Lung Cancer--A Report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group
- Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- Screening for Long QT Syndrome
- Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy
- Cost-utility analysis of chemotherapy in symptomatic advanced nonsmall cell lung cancer
- Bias in published cost effectiveness studies: systematic review
- The polypill: at what price would it become cost effective?
- Cost effectiveness of statins in coronary heart disease
- Cost-effectiveness of computerized tomographic colonography versus colonoscopy for colorectal cancer screening
- 2004 MacLean-Mueller Prize Enteral or parenteral nutrition for severe pancreatitis: a randomized controlled trial and health technology assessment
- Cost-Utility Analyses in Orthopaedic Surgery
- Health related quality of life in genital herpes: a pilot comparison of measures
- RCT of a Care Manager Intervention for Major Depression in Primary Care: 2-Year Costs for Patients With Physical vs Psychological Complaints
- Cost-Effectiveness of Enhancing Primary Care Depression Management on an Ongoing Basis
- Comparing the Costs, Risks, and Benefits of Competing Strategies for the Primary Prevention of Venous Thromboembolism
- La medecine a deux vitesses en deux temps
- The two-step to two-tier
- Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration
- National Institute for Clinical Excellence and its value judgments
- Health Care Technology Assessment: Basic Principles and Clinical Applications
- Cost effectiveness analysis of neonatal extracorporeal membrane oxygenation based on four year results from the UK Collaborative ECMO Trial
- Cost utility of screening and treatment for early age related macular degeneration with zinc and antioxidants
- Diabetes: Too Big and Too Bad to Ignore Any Longer
- Quantitative analysis of sponsorship bias in economic studies of antidepressants
- Within-Trial Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of Type 2 Diabetes
- The challenge of an increasingly expensive blood system
- Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures?
- The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea
- Screening for diabetic retinopathy in James Bay, Ontario: a cost-effectiveness analysis
- Economic Evaluationin Orthopaedics
- Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy
- Searching for El Dorado: the impossibility of finding the right rate
- Cost-Effectiveness of Chemotherapy in Non-Small-Cell Lung Cancer
- Medical Economics and the Assessment of Value in Cardiovascular Medicine: Part I
- An introduction to economic evaluation
- Economic Analysis of the TAX 317 Trial: Docetaxel Versus Best Supportive Care as Second-Line Therapy of Advanced Non-Small-Cell Lung Cancer
- Costs and Benefits of Carotid Endarterectomy and Associated Preoperative Arterial Imaging: A Systematic Review of Health Economic Literature
- Inclusion of drugs in provincial drug benefit programs: Who is making these decisions, and are they the right ones?
- Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation
- Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: The Canadian Implantable Defibrillator Study
- Users guide to the surgical literature: how to use an article on economic analysis
- Managing public payment for high-cost, high-benefit treatment: enzyme replacement therapy for Gaucher's disease in Ontario
- Deep brain stimulation in the treatment of Parkinson's disease: A cost-effectiveness analysis
- Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit
- Cost-Effectiveness of the Implantable Cardioverter-Defibrillator : Results From the Canadian Implantable Defibrillator Study (CIDS)
- Hepatocellular carcinoma: is surveillance cost effective?
- Systematic Overview of Cost-Utility Assessments in Oncology
- Understanding cost effectiveness: a detailed review
- Cost utility analysis of sildenafil compared with papaverine-phentolamine injections
- Cost-Effectiveness of Catheter Ablation in Patients With Ventricular Tachycardia
- Economics notes: Using cost effectiveness information
- Tamoxifen Should be Cost-Effective in Reducing Breast Cancer Risk in High-Risk Women
- Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis
- Two view mammography at incident screens: cost effectiveness analysis of policy options
- Considering the cost of CABG
- Cost-Effectiveness Analysis of Screening for Asymptomatic, Unruptured Intracranial Aneurysms : A Mathematical Model